{"id":53987,"date":"2023-08-28T13:29:26","date_gmt":"2023-08-28T17:29:26","guid":{"rendered":"https:\/\/ifintechworld.com\/investing\/immunogen-stock-jumps-after-licensing-deal-with-japans-takeda-pharmaceutical\/"},"modified":"2023-08-28T13:29:28","modified_gmt":"2023-08-28T17:29:28","slug":"immunogen-stock-jumps-after-licensing-deal-with-japans-takeda-pharmaceutical","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=53987","title":{"rendered":"ImmunoGen stock jumps after licensing deal with Japan\u2019s Takeda Pharmaceutical"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"WP-MKTW-0002446466\" role=\"document\">\n<p>Shares of ImmunoGen Inc.<br \/>\n        IMGN,<br \/>\n        <bg-quote field=\"percentchange\" format=\"0,000.00%\" channel=\"\/zigman2\/quotes\/208003500\/composite\" class=\"negative\">-5.39%<\/bg-quote><br \/>\n       jumped 1.7% in premarket trading Monday, after the Massachusetts-based drug maker announced a collaboration with Takeda Pharmaceutical Co. Ltd.<br \/>\n        TAK,<br \/>\n        <bg-quote field=\"percentchange\" format=\"0,000.00%\" channel=\"\/zigman2\/quotes\/204098703\/composite\" class=\"positive\">+0.16%<\/bg-quote><\/p>\n<p>        4502,<br \/>\n        <bg-quote field=\"percentchange\" format=\"0,000.00%\" channel=\"\/zigman2\/quotes\/201302442\/delayed\" class=\"positive\">+0.52%<\/bg-quote><br \/>\n       to commercialize its Elahere ovarian cancer treatment in Japan. Under terms of the collaboration, ImmunoGen will receive an upfront payment of $34 million, and will be eligible to receive additional payments as the U.S. Food and Drug Administration\u2019s accelerated approval of Elahere is converted to full approval, and as other regulatory and commercial milestones are met. Takeda will receive an exclusive license to commercialize Elahere in Japan and will be responsible for all regulatory filings. ImmunoGen\u2019s stock has rocketed 225.2% year to date through Friday, while the S&amp;P 500<br \/>\n        SPX,<br \/>\n        <bg-quote field=\"percentchange\" format=\"0,000.00%\" channel=\"\/zigman2\/quotes\/210599714\/realtime\" class=\"positive\">+0.63%<\/bg-quote><br \/>\n       has tacked on 14.8%.<\/p>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.marketwatch.com\/story\/immunogen-stock-jumps-after-licensing-deal-with-japans-takeda-pharmaceutical-239ceb12?mod=investing\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shares of ImmunoGen Inc. IMGN, -5.39% jumped 1.7% in premarket trading Monday, after the Massachusetts-based drug maker announced a collaboration with Takeda Pharmaceutical Co. Ltd. TAK, +0.16% 4502, +0.52% to commercialize its Elahere ovarian cancer treatment in Japan. Under terms of the collaboration, ImmunoGen will receive an upfront payment of $34 million, and will be [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1383,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[239],"tags":[83],"class_list":["post-53987","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-investing","tag-featured","post_format-post-format-video"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ImmunoGen stock jumps after licensing deal with Japan\u2019s Takeda Pharmaceutical | iFintechWorld<\/title>\n<meta name=\"description\" content=\"Shares of ImmunoGen Inc. IMGN, -5.39% jumped 1.7% in premarket trading Monday, after the Massachusetts-based drug maker announced a collaboration with\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=53987\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ImmunoGen stock jumps after licensing deal with Japan\u2019s Takeda Pharmaceutical | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"Shares of ImmunoGen Inc. IMGN, -5.39% jumped 1.7% in premarket trading Monday, after the Massachusetts-based drug maker announced a collaboration with\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=53987\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-28T17:29:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-28T17:29:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/MW-GP644_MicroS_ZG_20180906154215.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1320\" \/>\n\t<meta property=\"og:image:height\" content=\"742\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=53987#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=53987\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"ImmunoGen stock jumps after licensing deal with Japan\u2019s Takeda Pharmaceutical\",\"datePublished\":\"2023-08-28T17:29:26+00:00\",\"dateModified\":\"2023-08-28T17:29:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=53987\"},\"wordCount\":136,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=53987#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=53987\",\"url\":\"https:\/\/ifintechworld.com\/?p=53987\",\"name\":\"ImmunoGen stock jumps after licensing deal with Japan\u2019s Takeda Pharmaceutical | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-08-28T17:29:26+00:00\",\"dateModified\":\"2023-08-28T17:29:28+00:00\",\"description\":\"Shares of ImmunoGen Inc. IMGN, -5.39% jumped 1.7% in premarket trading Monday, after the Massachusetts-based drug maker announced a collaboration with\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=53987#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=53987\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=53987#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ImmunoGen stock jumps after licensing deal with Japan\u2019s Takeda Pharmaceutical\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ImmunoGen stock jumps after licensing deal with Japan\u2019s Takeda Pharmaceutical | iFintechWorld","description":"Shares of ImmunoGen Inc. IMGN, -5.39% jumped 1.7% in premarket trading Monday, after the Massachusetts-based drug maker announced a collaboration with","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=53987","og_locale":"en_US","og_type":"article","og_title":"ImmunoGen stock jumps after licensing deal with Japan\u2019s Takeda Pharmaceutical | iFintechWorld","og_description":"Shares of ImmunoGen Inc. IMGN, -5.39% jumped 1.7% in premarket trading Monday, after the Massachusetts-based drug maker announced a collaboration with","og_url":"https:\/\/ifintechworld.com\/?p=53987","og_site_name":"iFintechWorld","article_published_time":"2023-08-28T17:29:26+00:00","article_modified_time":"2023-08-28T17:29:28+00:00","og_image":[{"width":1320,"height":742,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/MW-GP644_MicroS_ZG_20180906154215.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=53987#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=53987"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"ImmunoGen stock jumps after licensing deal with Japan\u2019s Takeda Pharmaceutical","datePublished":"2023-08-28T17:29:26+00:00","dateModified":"2023-08-28T17:29:28+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=53987"},"wordCount":136,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=53987#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=53987","url":"https:\/\/ifintechworld.com\/?p=53987","name":"ImmunoGen stock jumps after licensing deal with Japan\u2019s Takeda Pharmaceutical | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-08-28T17:29:26+00:00","dateModified":"2023-08-28T17:29:28+00:00","description":"Shares of ImmunoGen Inc. IMGN, -5.39% jumped 1.7% in premarket trading Monday, after the Massachusetts-based drug maker announced a collaboration with","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=53987#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=53987"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=53987#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"ImmunoGen stock jumps after licensing deal with Japan\u2019s Takeda Pharmaceutical"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/53987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=53987"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/53987\/revisions"}],"predecessor-version":[{"id":53988,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/53987\/revisions\/53988"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/1383"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=53987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=53987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=53987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}